ScinoPharm Invests in High Potency Facility

06:39 AM | July 3, 2012 | Deepti Ramesh

Active pharmaceutical ingredient (API) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says it will invest NT$1.13 billion ($38 million) to build a high potency cytotoxic injectable plant for...